Product overview
Type
Human Papillomavirus (Bivalent)
Commercial Name
Cervarix
Manufacturer
GlaxoSmithKline Biologicals SA
URL
Responsible NRA
Federal Agency for Medicines and Health Products
Country
Belgium
Prequalification
Prequalification Status
Current
Product description
Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
2
Diluent
Not Applicable
Route of Administration
Intramuscular
Shelf Life
60 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 30
Secondary Packaging
a. Carton of 1 vial [Dimensions 3.1x3.1xb. Carton of 10 vials [Dimensions 8.4x3.7x3.7 cm]; c. Carton of 100 vials [Dimensions 17.8x14.7x3.7]
Tertiary Packaging
Box of 24 cartons of 100 vials (4800 doses) [Dimensions 34x25x43 cm]
Multidose Vial Policy
WHO recommends that opened vials of this vaccine should be discarded 6 hours after opening or at the end of the immunization session, whichever comes first.
Vaccine Preservative
none
Cold Chain Volume
a) 28.8; b)5.7; c) 4.8 cm3/dose (in secondary packaging)
Attachments